Intermountain is a learning healthcare system. By making investigational treatment options available in addition to best-practice supportive care, Intermountain hopes to help more people recover while also learning which treatments are effective.
The only way to truly know whether a drug or treatment is effective for a particular illness or disease and safe for broad use, is through the controlled setting of clinical trials. Clinical trials are critical to finding ways to improve outcomes and reduce the human costs of pandemics such as COVID-19. Several medications that are FDA-approved for other conditions have received a lot of attention for their potential to treat COVID-19. However, medical studies have not yet confirmed whether these treatments help or harm patients.
This is a challenging and alarming time for patients and healthcare providers. Clinicians sometimes face pressure to prescribe these medications even though we don’t have evidence that they work. COVID-19 experts and leaders at Intermountain Healthcare and the University of Utah are working together with the Governor’s COVID-19 task force to launch clinical trials that provide access to these medications for Utahns in a safe way that will also help us to know how best to care for patients in the future.
We are therefore grateful for the opportunity to participate in the society-wide effort to beat COVID-19 through the development of high-quality clinical trials for patients with COVID-19.
Information about current COVID-19 clinical trials will be updated below: